AMD President and CEO Dr. Lisa Su to Keynote at CES 2019
SANTA CLARA, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced that Dr. Lisa Su, president and chief executive officer, will present a keynote address at CES 2019. Dr. Su's presentation is scheduled for Wednesday, Jan. 9 at 9:00 a.m. PST in the Venetian Palazzo Ballroom.
A live stream of the event will be available at: https://www.youtube.com/c/AMD/live. An archived version of the webcast will be available approximately one hour after the event and can be found on the AMD YouTube channel.
About AMD
For more than 45 years AMD has driven innovation in high-performance computing, graphics and visualization technologies -- the building blocks for gaming, immersive platforms and the datacenter. Hundreds of millions of consumers, leading Fortune 500 businesses and cutting-edge scientific research facilities around the world rely on AMD technology daily to improve how they live, work and play. AMD employees around the world are focused on building great products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website, blog, Facebook and Twitter.
AMD, the AMD Arrow logo and the combination thereof are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners
Contact: Drew Prairie AMD Public Relations (512) 602-4425 [email protected]
Investor Contact Jason Schmidt AMD Investor Relations 408-749-6688 [email protected]
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024).
The campaign focuses on access to IBD care and treatment as the burden of...
The global industrial automation market in life sciences industry size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.4% during the forecast period. ...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...